Latest News for: immunoglobulin

Edit

Anti CD19 monoclonal antibody UPLIZNAⓇ for I.V. Infusion 100mg Application for additional indication of immunoglobulin G4 related disease in Japan[PDF:435.6 KB] (Mitsubishi Tanabe Pharma Corporation)

Public Technologies 21 Mar 2025
immunoglobulin G4-related disease in Japan ... Inebilizumab (Genetical Recombination), hereinafter UPLIZNA) for the treatment of immunoglobulin G4-related disease (IgG4-RD) on March 19, 2025.
Edit

【Mitsubishi Tanabe Pharma】Anti CD19 monoclonal antibody UPLIZNA® for I.V. Infusion 100mg Application for additional indication of immunoglobulin G4 related disease in JapanNEW (Mitsubishi Chemical Group Corporation)

Public Technologies 21 Mar 2025
immunoglobulin G4-related disease in Japan ... Inebilizumab (Genetical Recombination), hereinafter UPLIZNA) for the treatment of immunoglobulin G4-related disease (IgG4-RD) on March 19, 2025.
Edit

The relationship between gut microbiota, immunoglobulin A, and vaccine efficacy

Science Daily 13 Mar 2025
A study has established the importance of immunoglobulin A, an antibody that is ...
Edit

Grifols Phase 2/3 trial shows positive impact of immunoglobulin therapy on post-polio patients (Grifols SA)

Public Technologies 13 Mar 2025
March 13, 2025 Grifols Phase 2/3 trial shows positive impact of immunoglobulin therapy on post-polio patients.
  • 1
×